Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation

Manzia, Tommaso Maria;Angelico, Roberta;Toti, Luca;Lai, Quirino;Tisone, Giuseppe;et.al.
(2012) Expert Review of Clinical Immunology — Vol. 8, n° 7, p. 635-644 (2012)

Files

No attached file found for this publication.

Details

Authors
  • Manzia, Tommaso Maria
    Author
  • Angelico, Roberta
    Author
  • Toti, Luca
    Author
  • Lai, QuirinoUCLouvain
    Author
  • Tisone, Giuseppe
    Author
Show more
Abstract
HCV-related disease is the most common indication for liver transplantation (LT). HCV recurrence, which is almost universal, has a significant impact on patient and graft survival after LT and still represents a great unsolved issue for the liver transplant community. Several treatment strategies have been proposed. Since antiviral therapy has limited efficacy and can be administrated only in selected transplant recipients and additionally that immunosuppressive drugs have a negative impact on HCV re-infection, the achievement of an immunosuppression-free state after LT could play a central role in the avoidance of rapid HCV recurrence. © 2012 Expert Reviews Ltd.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Manzia, T. M., Angelico, R., Toti, L., Lai, Q., Ciano, P., Angelico, M., & Tisone, G. (2012). Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. Expert Review of Clinical Immunology, 8(7), 635-644. https://doi.org/10.1586/eci.12.66 (Original work published 2012)